New drugs cause fundamental shift in Europe’s drug market
28-05-2013
The number, type and availability of new drugs in Europe continued to increase in 2012, according to a report released today by the EMCDDA and Europol. Driven by globalisation, technological advancement and the Internet, an open market for new...
Read more